Concepedia

Lisa S. Wang

LS

2

Publications

48

Citations

2

H-Index

2021

Active since

Affiliations

Massachusetts General Hospital(Current)

University of California, Los Angeles

UCLA Jonsson Comprehensive Cancer Center

PIH Health

Lisa S. Wang is an author at Massachusetts General Hospital specializing in pharmacology, breast cancer, and cancer therapeutics.

Top concepts

Publications per year

2021–2022

2

Publications

2

TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early-stage breast cancer.

Sara A. Hurvitz, Lisa S. Wang, David W. Chan et al. · Journal of Clinical Oncology · 2022 · 37 citations

, , +15

TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer.

Sara A. Hurvitz, Parvin F. Peddi, Merry Tetef et al. · Journal of Clinical Oncology · 2021 · 11 citations

Rows per page

1–2 of 2